Exhibit 107
Calculation of Filing Fee Tables
| Form S-8 |
| (Form Type) |
| Ocular Therapeutix, Inc. |
| (Exact Name of Registrant as Specified in its Charter) |
Table 1—Newly Registered Securities
Security
Type | | Security Class
Title | | Fee
Calculation
Rule | | Amount
Registered
(1) | | Proposed
Maximum
Offering
Price Per
Unit | | | Maximum
Aggregate
Offering Price | | | Fee Rate | | Amount of
Registration
Fee | |
| Equity | | Common Stock, $0.0001 par value per share | | Other | | 207,402 shares (2) | | | $4.87 (3) | | | | $1,010,047.74 (3) | | | $92.70
per $1,000,000 | | | $93.64 | |
| Total Offering Amounts | | | | | | | $1,010,047.74 | | | | | | $93.64 | |
| Total Fee Offsets | | | | | | | | | | | | | — | |
| Net Fee Due | | | | | | | | | | | | | $93.64 | |
| (1) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
| (2) | Consists of 207,402 shares issuable under the 2014 Employee Stock Purchase Plan (the “2014 ESPP”). |
| (3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The price per share and aggregate offering price are calculated on the basis of the average of the high and low sale prices of the registrant’s common stock on the Nasdaq Global Market on February 23, 2022, in accordance with Rule 457(c) under the Securities Act. |
